Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2004-09-06

AUTHORS

Isaac Yi Kim, Dong-Hyeon Lee, Dug Keun Lee, Han-Jong Ahn, Moses M Kim, Seong Jin Kim, Ronald A Morton

ABSTRACT

Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β superfamily and signal through a number of membrane receptors. We have previously demonstrated that the loss of expression of BMP receptors (BMPRs) type IA, -IB, and -II (BMP-RIA, -RIB, and -RII) correlates with Gleason score in prostate cancer patients. To evaluate the prognostic value of this observation, we used immunohistochemistry to investigate the expression of BMPRs in association with disease progression in 60 patients. The results demonstrated a significant association between the loss of expression of the three BMPRs and Gleason score and clinical stage. However, only the loss of expression of BMP-RII showed a statistically significant association with 5-year survival rate (P<0.05) and biochemical recurrence-free rate following radical prostatectomy (P<0.005). To elucidate the effect of an abnormal BMP signaling in prostate cancer cells, we transfected dominant-negative BMP-RII (BMP-RIIDN) into the human prostate cancer cell line, PC3M. When a stable clone overexpressing BMP-RIIDN was inoculated subcutaneously into nude mice, the tumor growth rate was approximately 10 times that of control and parental cell line. These observations, taken together, indicate that the loss of BMP-RII expression as measured by immunohistochemistry may be a prognostic marker in prostate cancer patients, and that the loss of BMP-RII function may result in increased tumorigenicity in human prostate cancer cells. More... »

PAGES

7651-7659

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.onc.1207924

DOI

http://dx.doi.org/10.1038/sj.onc.1207924

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1032792224

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15354178


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Morphogenetic Protein Receptors, Type II", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein-Serine-Threonine Kinases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Urology, University of California, Irvine, 92868, Orange, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.266093.8", 
          "name": [
            "Scott Department of Urology, Baylor College of Medicine, 77030, Houston, TX, USA", 
            "Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 20892, Bethesda, MD, USA", 
            "Department of Urology, University of California, Irvine, 92868, Orange, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Isaac Yi", 
        "id": "sg:person.0656765204.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656765204.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Ewha Women\u2019s University, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.255649.9", 
          "name": [
            "Department of Urology, Ewha Women\u2019s University, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong-Hyeon", 
        "id": "sg:person.013204130620.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013204130620.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 20892, Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 20892, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dug Keun", 
        "id": "sg:person.01200532302.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200532302.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Urology, Asan Medical Center, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.413967.e", 
          "name": [
            "Department of Urology, Asan Medical Center, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahn", 
        "givenName": "Han-Jong", 
        "id": "sg:person.013434134112.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013434134112.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Scott Department of Urology, Baylor College of Medicine, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Scott Department of Urology, Baylor College of Medicine, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Moses M", 
        "id": "sg:person.0630673464.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630673464.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 20892, Bethesda, MD, USA", 
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "name": [
            "Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 20892, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Seong Jin", 
        "id": "sg:person.0706536533.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706536533.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Scott Department of Urology, Baylor College of Medicine, 77030, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.39382.33", 
          "name": [
            "Scott Department of Urology, Baylor College of Medicine, 77030, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morton", 
        "givenName": "Ronald A", 
        "id": "sg:person.01103430664.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103430664.81"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bjc.1996.108", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003942472", 
          "https://doi.org/10.1038/bjc.1996.108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1998.658", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018880454", 
          "https://doi.org/10.1038/bjc.1998.658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1200964", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002522192", 
          "https://doi.org/10.1038/sj.onc.1200964"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2004-09-06", 
    "datePublishedReg": "2004-09-06", 
    "description": "Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-\u03b2 superfamily and signal through a number of membrane receptors. We have previously demonstrated that the loss of expression of BMP receptors (BMPRs) type IA, -IB, and -II (BMP-RIA, -RIB, and -RII) correlates with Gleason score in prostate cancer patients. To evaluate the prognostic value of this observation, we used immunohistochemistry to investigate the expression of BMPRs in association with disease progression in 60 patients. The results demonstrated a significant association between the loss of expression of the three BMPRs and Gleason score and clinical stage. However, only the loss of expression of BMP-RII showed a statistically significant association with 5-year survival rate (P<0.05) and biochemical recurrence-free rate following radical prostatectomy (P<0.005). To elucidate the effect of an abnormal BMP signaling in prostate cancer cells, we transfected dominant-negative BMP-RII (BMP-RIIDN) into the human prostate cancer cell line, PC3M. When a stable clone overexpressing BMP-RIIDN was inoculated subcutaneously into nude mice, the tumor growth rate was approximately 10 times that of control and parental cell line. These observations, taken together, indicate that the loss of BMP-RII expression as measured by immunohistochemistry may be a prognostic marker in prostate cancer patients, and that the loss of BMP-RII function may result in increased tumorigenicity in human prostate cancer cells.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.onc.1207924", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2710036", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "46", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "23"
      }
    ], 
    "keywords": [
      "bone morphogenetic protein", 
      "prostate cancer cells", 
      "human prostate cancer cells", 
      "loss of expression", 
      "prostate cancer patients", 
      "BMP-RII", 
      "Gleason score", 
      "cancer patients", 
      "BMP receptor type IA", 
      "bone morphogenetic protein receptor type II", 
      "cancer cells", 
      "significant association", 
      "human prostate cancer cell lines", 
      "biochemical recurrence-free rate", 
      "expression of BMPRs", 
      "recurrence-free rate", 
      "prostate cancer cell lines", 
      "cell lines", 
      "tumor growth rate", 
      "receptor type II", 
      "cancer cell lines", 
      "parental cell line", 
      "morphogenetic proteins", 
      "clinical stage", 
      "prognostic value", 
      "radical prostatectomy", 
      "disease progression", 
      "prognostic marker", 
      "membrane receptors", 
      "nude mice", 
      "survival rate", 
      "stable clones", 
      "patients", 
      "growth factor", 
      "BMPR", 
      "expression", 
      "immunohistochemistry", 
      "association", 
      "type II", 
      "growth rate", 
      "cells", 
      "scores", 
      "superfamily", 
      "type Ia", 
      "prostatectomy", 
      "protein", 
      "mice", 
      "clones", 
      "progression", 
      "receptors", 
      "loss", 
      "tumorigenicity", 
      "rate", 
      "markers", 
      "lines", 
      "IB", 
      "IA", 
      "members", 
      "factors", 
      "control", 
      "effect", 
      "function", 
      "stage", 
      "observations", 
      "number", 
      "time", 
      "results", 
      "values", 
      "receptors (BMPRs) type IA", 
      "abnormal BMP", 
      "dominant-negative BMP-RII", 
      "PC3M.", 
      "BMP-RIIDN", 
      "BMP-RII expression", 
      "BMP-RII function", 
      "morphogenetic protein receptor type II", 
      "protein receptor type II"
    ], 
    "name": "Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells", 
    "pagination": "7651-7659", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1032792224"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.onc.1207924"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15354178"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.onc.1207924", 
      "https://app.dimensions.ai/details/publication/pub.1032792224"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_393.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.onc.1207924"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1207924'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1207924'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1207924'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.onc.1207924'


 

This table displays all metadata directly associated to this object as RDF triples.

249 TRIPLES      22 PREDICATES      116 URIs      105 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.onc.1207924 schema:about N1803c42042ea4398bab9f6fc1eb2520b
2 N70a084309fab462da8da3d1a67c355fb
3 N9e67c9d52a054aa9bd80df24fa6ea70f
4 Na7c3fd3efafc42c9931d698a79efefe9
5 Nc32253dc52754935b60f427da09e716c
6 Nc93b8d4ed3b34708bd9aeffc9c982b6c
7 Nd6eeb336e1a348a3a076f418b6aa429b
8 Nda348a1367c845b892c5be2ea54b1e21
9 Neb329dbd62f7433cb171c13365231bc6
10 Nfbe8c5d5a0f24245af00f38881c790b8
11 anzsrc-for:11
12 anzsrc-for:1112
13 schema:author Nf2ae9d24a4d34d90b29e104baef3ba37
14 schema:citation sg:pub.10.1038/bjc.1996.108
15 sg:pub.10.1038/bjc.1998.658
16 sg:pub.10.1038/sj.onc.1200964
17 schema:datePublished 2004-09-06
18 schema:datePublishedReg 2004-09-06
19 schema:description Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-β superfamily and signal through a number of membrane receptors. We have previously demonstrated that the loss of expression of BMP receptors (BMPRs) type IA, -IB, and -II (BMP-RIA, -RIB, and -RII) correlates with Gleason score in prostate cancer patients. To evaluate the prognostic value of this observation, we used immunohistochemistry to investigate the expression of BMPRs in association with disease progression in 60 patients. The results demonstrated a significant association between the loss of expression of the three BMPRs and Gleason score and clinical stage. However, only the loss of expression of BMP-RII showed a statistically significant association with 5-year survival rate (P<0.05) and biochemical recurrence-free rate following radical prostatectomy (P<0.005). To elucidate the effect of an abnormal BMP signaling in prostate cancer cells, we transfected dominant-negative BMP-RII (BMP-RIIDN) into the human prostate cancer cell line, PC3M. When a stable clone overexpressing BMP-RIIDN was inoculated subcutaneously into nude mice, the tumor growth rate was approximately 10 times that of control and parental cell line. These observations, taken together, indicate that the loss of BMP-RII expression as measured by immunohistochemistry may be a prognostic marker in prostate cancer patients, and that the loss of BMP-RII function may result in increased tumorigenicity in human prostate cancer cells.
20 schema:genre article
21 schema:inLanguage en
22 schema:isAccessibleForFree true
23 schema:isPartOf N16461bc4849c456a8b12ef0901e4a2b3
24 N928954ef04c4431389c80977c0d10a2e
25 sg:journal.1097543
26 schema:keywords BMP receptor type IA
27 BMP-RII
28 BMP-RII expression
29 BMP-RII function
30 BMP-RIIDN
31 BMPR
32 Gleason score
33 IA
34 IB
35 PC3M.
36 abnormal BMP
37 association
38 biochemical recurrence-free rate
39 bone morphogenetic protein
40 bone morphogenetic protein receptor type II
41 cancer cell lines
42 cancer cells
43 cancer patients
44 cell lines
45 cells
46 clinical stage
47 clones
48 control
49 disease progression
50 dominant-negative BMP-RII
51 effect
52 expression
53 expression of BMPRs
54 factors
55 function
56 growth factor
57 growth rate
58 human prostate cancer cell lines
59 human prostate cancer cells
60 immunohistochemistry
61 lines
62 loss
63 loss of expression
64 markers
65 members
66 membrane receptors
67 mice
68 morphogenetic protein receptor type II
69 morphogenetic proteins
70 nude mice
71 number
72 observations
73 parental cell line
74 patients
75 prognostic marker
76 prognostic value
77 progression
78 prostate cancer cell lines
79 prostate cancer cells
80 prostate cancer patients
81 prostatectomy
82 protein
83 protein receptor type II
84 radical prostatectomy
85 rate
86 receptor type II
87 receptors
88 receptors (BMPRs) type IA
89 recurrence-free rate
90 results
91 scores
92 significant association
93 stable clones
94 stage
95 superfamily
96 survival rate
97 time
98 tumor growth rate
99 tumorigenicity
100 type II
101 type Ia
102 values
103 schema:name Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells
104 schema:pagination 7651-7659
105 schema:productId N7e12c8fd7a4d4cbaaf5494f10390863f
106 Na2aebc04256c4cad9f6478cef96e437d
107 Ne9dbdd12dfcb47da8517f9ced26eee66
108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032792224
109 https://doi.org/10.1038/sj.onc.1207924
110 schema:sdDatePublished 2022-01-01T18:14
111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
112 schema:sdPublisher Nd6ada64cb19149e38532c19f06241a73
113 schema:url https://doi.org/10.1038/sj.onc.1207924
114 sgo:license sg:explorer/license/
115 sgo:sdDataset articles
116 rdf:type schema:ScholarlyArticle
117 N16461bc4849c456a8b12ef0901e4a2b3 schema:volumeNumber 23
118 rdf:type schema:PublicationVolume
119 N1803c42042ea4398bab9f6fc1eb2520b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Neoplasm Staging
121 rdf:type schema:DefinedTerm
122 N3e7bca783bc54b0fa2039cf8c43ce36a rdf:first sg:person.0630673464.49
123 rdf:rest Ne47a6e3f15074aaab9fdd47de785e05d
124 N70a084309fab462da8da3d1a67c355fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Protein-Serine-Threonine Kinases
126 rdf:type schema:DefinedTerm
127 N7e12c8fd7a4d4cbaaf5494f10390863f schema:name pubmed_id
128 schema:value 15354178
129 rdf:type schema:PropertyValue
130 N86c76ac263984d469ad2a50712a88479 rdf:first sg:person.013204130620.88
131 rdf:rest Ndf4c701f61c54534bc4c475f523d7049
132 N928954ef04c4431389c80977c0d10a2e schema:issueNumber 46
133 rdf:type schema:PublicationIssue
134 N96479631d9094025ade565fa1e39cea6 rdf:first sg:person.01103430664.81
135 rdf:rest rdf:nil
136 N9e67c9d52a054aa9bd80df24fa6ea70f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Prostatic Neoplasms
138 rdf:type schema:DefinedTerm
139 Na2aebc04256c4cad9f6478cef96e437d schema:name dimensions_id
140 schema:value pub.1032792224
141 rdf:type schema:PropertyValue
142 Na7c3fd3efafc42c9931d698a79efefe9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Gene Expression Regulation, Neoplastic
144 rdf:type schema:DefinedTerm
145 Nc32253dc52754935b60f427da09e716c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Disease Progression
147 rdf:type schema:DefinedTerm
148 Nc93b8d4ed3b34708bd9aeffc9c982b6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Prostate
150 rdf:type schema:DefinedTerm
151 Ncb1ea1acab904efe985ff4609619f5a7 rdf:first sg:person.013434134112.48
152 rdf:rest N3e7bca783bc54b0fa2039cf8c43ce36a
153 Nd6ada64cb19149e38532c19f06241a73 schema:name Springer Nature - SN SciGraph project
154 rdf:type schema:Organization
155 Nd6eeb336e1a348a3a076f418b6aa429b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Humans
157 rdf:type schema:DefinedTerm
158 Nda348a1367c845b892c5be2ea54b1e21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Male
160 rdf:type schema:DefinedTerm
161 Ndf4c701f61c54534bc4c475f523d7049 rdf:first sg:person.01200532302.03
162 rdf:rest Ncb1ea1acab904efe985ff4609619f5a7
163 Ne47a6e3f15074aaab9fdd47de785e05d rdf:first sg:person.0706536533.42
164 rdf:rest N96479631d9094025ade565fa1e39cea6
165 Ne9dbdd12dfcb47da8517f9ced26eee66 schema:name doi
166 schema:value 10.1038/sj.onc.1207924
167 rdf:type schema:PropertyValue
168 Neb329dbd62f7433cb171c13365231bc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Tumor Cells, Cultured
170 rdf:type schema:DefinedTerm
171 Nf2ae9d24a4d34d90b29e104baef3ba37 rdf:first sg:person.0656765204.32
172 rdf:rest N86c76ac263984d469ad2a50712a88479
173 Nfbe8c5d5a0f24245af00f38881c790b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Bone Morphogenetic Protein Receptors, Type II
175 rdf:type schema:DefinedTerm
176 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
177 schema:name Medical and Health Sciences
178 rdf:type schema:DefinedTerm
179 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
180 schema:name Oncology and Carcinogenesis
181 rdf:type schema:DefinedTerm
182 sg:grant.2710036 http://pending.schema.org/fundedItem sg:pub.10.1038/sj.onc.1207924
183 rdf:type schema:MonetaryGrant
184 sg:journal.1097543 schema:issn 0950-9232
185 1476-5594
186 schema:name Oncogene
187 schema:publisher Springer Nature
188 rdf:type schema:Periodical
189 sg:person.01103430664.81 schema:affiliation grid-institutes:grid.39382.33
190 schema:familyName Morton
191 schema:givenName Ronald A
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103430664.81
193 rdf:type schema:Person
194 sg:person.01200532302.03 schema:affiliation grid-institutes:grid.48336.3a
195 schema:familyName Lee
196 schema:givenName Dug Keun
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200532302.03
198 rdf:type schema:Person
199 sg:person.013204130620.88 schema:affiliation grid-institutes:grid.255649.9
200 schema:familyName Lee
201 schema:givenName Dong-Hyeon
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013204130620.88
203 rdf:type schema:Person
204 sg:person.013434134112.48 schema:affiliation grid-institutes:grid.413967.e
205 schema:familyName Ahn
206 schema:givenName Han-Jong
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013434134112.48
208 rdf:type schema:Person
209 sg:person.0630673464.49 schema:affiliation grid-institutes:grid.39382.33
210 schema:familyName Kim
211 schema:givenName Moses M
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0630673464.49
213 rdf:type schema:Person
214 sg:person.0656765204.32 schema:affiliation grid-institutes:grid.266093.8
215 schema:familyName Kim
216 schema:givenName Isaac Yi
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656765204.32
218 rdf:type schema:Person
219 sg:person.0706536533.42 schema:affiliation grid-institutes:grid.48336.3a
220 schema:familyName Kim
221 schema:givenName Seong Jin
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706536533.42
223 rdf:type schema:Person
224 sg:pub.10.1038/bjc.1996.108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003942472
225 https://doi.org/10.1038/bjc.1996.108
226 rdf:type schema:CreativeWork
227 sg:pub.10.1038/bjc.1998.658 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018880454
228 https://doi.org/10.1038/bjc.1998.658
229 rdf:type schema:CreativeWork
230 sg:pub.10.1038/sj.onc.1200964 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002522192
231 https://doi.org/10.1038/sj.onc.1200964
232 rdf:type schema:CreativeWork
233 grid-institutes:grid.255649.9 schema:alternateName Department of Urology, Ewha Women’s University, Seoul, Korea
234 schema:name Department of Urology, Ewha Women’s University, Seoul, Korea
235 rdf:type schema:Organization
236 grid-institutes:grid.266093.8 schema:alternateName Department of Urology, University of California, Irvine, 92868, Orange, CA, USA
237 schema:name Department of Urology, University of California, Irvine, 92868, Orange, CA, USA
238 Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 20892, Bethesda, MD, USA
239 Scott Department of Urology, Baylor College of Medicine, 77030, Houston, TX, USA
240 rdf:type schema:Organization
241 grid-institutes:grid.39382.33 schema:alternateName Scott Department of Urology, Baylor College of Medicine, 77030, Houston, TX, USA
242 schema:name Scott Department of Urology, Baylor College of Medicine, 77030, Houston, TX, USA
243 rdf:type schema:Organization
244 grid-institutes:grid.413967.e schema:alternateName Department of Urology, Asan Medical Center, Seoul, Korea
245 schema:name Department of Urology, Asan Medical Center, Seoul, Korea
246 rdf:type schema:Organization
247 grid-institutes:grid.48336.3a schema:alternateName Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 20892, Bethesda, MD, USA
248 schema:name Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 20892, Bethesda, MD, USA
249 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...